BCL2 and neoplasm: We have shown that the levels of IKKβ and BCL2 tend to be higher in tumor cell lines that have high basal NRF2 activity, suggesting that mutant or low/absent levels of KEAP1 may contribute to elevated IKKβ and BCL2 levels.